My Alzheimer's Journey
Part 152 - Changes!
Hello Friends,
I have an important announcement regarding the future structure of My Alzheimer’s Journey. To better serve this community and ensure the sustainability of my work, I am splitting the blog into two separate, focused publications.
1. My Alzheimer’s Journey (Current Blog)
Focus: My personal journey as an Alzheimer’s patient, delivered with authenticity and humor.
Frequency: Once per week. Most likely Friday.
Cost: Free, voluntary donations are appreciated.
2. Greg’s Alzheimer’s Research Report
Focus: Comprehensive, technical, and commercial intelligence on Alzheimer’s disease.
Content Includes: New treatments, clinical trials, emerging research, scientific conferences, and biotech/pharmaceutical updates.
Frequency: Five times per week (Monday – Friday).
Cost: Subscription required ($10/month or $100/year).
My goal is to give each publication the attention it deserves. While Alzheimer’s research and my journey as someone with Alzheimer’s disease are intertwined, the writing style, or narrative, is different. With separate publications, I can share my journey in a casual and authentic style. The research publication will have a more structured format.
You will continue to receive my weekly personal posts here, free of charge. For those who want daily, in-depth scientific reporting, the new publication is designed specifically for you.
Greg’s Alzheimer’s Research Report is not a newsletter you have to find time to read - it’s the one that saves you time. I cut through the noise of the scientific community to bring you the latest updates on Alzheimer’s research.
Deep Research, Plain English: I summarize the most complex, technical, and scientific information on Alzheimer’s disease and new treatments, delivering it in clear, understandable language.
Daily, Focused Updates: Receive a new publication Monday through Friday, ensuring you are current in the fast-moving world of Alzheimer’s research and clinical trials.
Save Hours of Searching: Stop wading through on-line scientific journals and press releases. My carefully researched articles consolidate information on:
New Treatment Research and Updates
In-Depth Clinical Trial Information (including Phase 3 trials like Masupirdine and registrational development like Diranersen)
Biotech and Pharmaceutical Company Movements
Coverage of Scientific Conferences (like AAIC)
Fast & Convenient: Each issue is designed to be a fast, 10-minute read, integrating seamlessly into your busy schedule.
Trusted Independent Voice: As a patient with Alzheimer’s, my personal interest guarantees the research is relevant and crucial to our community.
The Value Proposition: Essential Intelligence for Less Than a Cup of Coffee
· Access to this level of consistency, expertly curated, and patient-focused analysis is invaluable. The subscription is priced at just $10 per month, or you can receive a significant discount by choosing the annual plan for $100 per year.
· For less than 42 cents per publication (or as low as 38 cents with the annual plan), you get daily access to the critical information you need—freeing you from spending hours researching and ensuring you are always informed about the latest options and breakthroughs.
Greg’s Alzheimer’s Research Report is live with a new article published today. There is a free seven-day trial available.
Thank you for your support. I look forward to our continued friendship.
With gratitude,
Greg
Donations
Go Fund Me (amounts greater than $25)
Buy Big Bit A Treat (small donations)
Amazon Wish List (things that Linda and Greg need)
Shopping
About
Interested In Greg Speaking At Your Event?
Search